Literature DB >> 18252759

The Na+/Ca2+ exchange blocker SEA0400 fails to enhance cytosolic Ca2+ transient and contractility in canine ventricular cardiomyocytes.

Péter Birinyi1, András Tóth, István Jóna, Károly Acsai, János Almássy, Norbert Nagy, János Prorok, Iuliana Gherasim, Zoltán Papp, Zita Hertelendi, Norbert Szentandrássy, Tamás Bányász, Ferenc Fülöp, Julius Gy Papp, András Varró, Péter P Nánási, János Magyar.   

Abstract

AIMS: This study was designed to evaluate the effects of the Na(+)/Ca(2+) exchange (NCX) inhibitor SEA0400 on Ca(2+) handling in isolated canine ventricular myocytes. METHODS AND
RESULTS: Intracellular Ca(2+) ([Ca(2+)](i)) transients, induced by either field stimulation or caffeine flush, were monitored using Ca(2+) indicator dyes. [Ca(2+)](i)-dependent modulation of the inhibitory effect of SEA0400 on NCX was characterized by the changes in Ni(2+)-sensitive current in voltage-clamped myocytes. Sarcoplasmic reticulum (SR) Ca(2+) release and uptake were studied in SR membrane vesicles. Gating properties of single-ryanodine receptors were analysed in lipid bilayers. Ca(2+) sensitivity of the contractile machinery was evaluated in chemically skinned myocytes. In myocytes paced at 1 Hz, neither diastolic [Ca(2+)](i) nor the amplitude of [Ca(2+)](i) transients was significantly altered by SEA0400 up to the concentration of 1 microM, which was shown to inhibit the exchange current. The blocking effect of SEA0400 on NCX decreased with increasing [Ca(2+)](i), and it was more pronounced in reverse than in forward mode operation at every [Ca(2+)](i) examined. The rate of decay of the caffeine-induced [Ca(2+)](i) transients was decreased significantly by 1 microM SEA0400; however, this effect was only a fraction of that observed with 10 mM NiCl(2). Neither SR Ca(2+) release and uptake nor cell shortening and Ca(2+) sensitivity of the contractile proteins were influenced by SEA0400.
CONCLUSION: The lack of any major SEA0400-induced shift in Ca(2+) transients or contractility of myocytes can well be explained by its limited inhibitory effect on NCX (further attenuated by elevated [Ca(2+)](i) levels) and a concomitant reduction in Ca(2+) influx due to the predominantly reverse mode blockade of NCX and suppression of L-type Ca(2+) current.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18252759     DOI: 10.1093/cvr/cvn031

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  10 in total

1.  Chronic administration of KB-R7943 induces up-regulation of cardiac NCX1.

Authors:  Lin Xu; Christiana S Kappler; Santhosh K Mani; Neal R Shepherd; Ludivine Renaud; Paige Snider; Simon J Conway; Donald R Menick
Journal:  J Biol Chem       Date:  2009-08-06       Impact factor: 5.157

2.  Echinochrome A regulates phosphorylation of phospholamban Ser16 and Thr17 suppressing cardiac SERCA2A Ca²⁺ reuptake.

Authors:  Hyoung Kyu Kim; Jae Boum Youm; Seung Hun Jeong; Sung Ryul Lee; In-Sung Song; Tae Hee Ko; Julius Ryan Pronto; Kyung Soo Ko; Byoung Doo Rhee; Nari Kim; Bernd Nilius; Natalia P Mischchenko; Sergey A Fedoreyev; Valentin A Stonik; Jin Han
Journal:  Pflugers Arch       Date:  2014-11-21       Impact factor: 3.657

3.  SEA0400 fails to alter the magnitude of intracellular Ca2+ transients and contractions in Langendorff-perfused guinea pig heart.

Authors:  Norbert Szentandrássy; Péter Birinyi; Gyula Szigeti; Attila Farkas; János Magyar; András Tóth; László Csernoch; András Varró; Péter P Nánási
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-05-06       Impact factor: 3.000

Review 4.  Control of cardiac contraction by sodium: Promises, reckonings, and new beginnings.

Authors:  Donald W Hilgemann
Journal:  Cell Calcium       Date:  2019-11-22       Impact factor: 6.817

5.  Selective Na(+) /Ca(2+) exchanger inhibition prevents Ca(2+) overload-induced triggered arrhythmias.

Authors:  Norbert Nagy; Anita Kormos; Zsófia Kohajda; Áron Szebeni; Judit Szepesi; Piero Pollesello; Jouko Levijoki; Károly Acsai; László Virág; Péter P Nánási; Julius Gy Papp; András Varró; András Tóth
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

6.  Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype.

Authors:  Joachim Seegers; Marc A Vos; Panagiota Flevari; Rik Willems; Christian Sohns; Dirk Vollmann; Lars Lüthje; Dimitrios T Kremastinos; Vincent Floré; Mathias Meine; Anton Tuinenburg; Rachel C Myles; Dirk Simon; Jürgen Brockmöller; Tim Friede; Gerd Hasenfuß; Stephan E Lehnart; Markus Zabel
Journal:  Europace       Date:  2011-11-23       Impact factor: 5.214

7.  Herpesvirus-mediated delivery of a genetically encoded fluorescent Ca(2+) sensor to canine cardiomyocytes.

Authors:  János Prorok; Péter P Kovács; Attila A Kristóf; Norbert Nagy; Dóra Tombácz; Judit S Tóth; Balázs Ordög; Norbert Jost; László Virág; Julius G Papp; András Varró; András Tóth; Zsolt Boldogkoi
Journal:  J Biomed Biotechnol       Date:  2009-07-14

8.  Regulation of APD and Force by the Na+/Ca2+ Exchanger in Human-Induced Pluripotent Stem Cell-Derived Engineered Heart Tissue.

Authors:  Djemail Ismaili; Katrin Gurr; András Horváth; Lei Yuan; Marc D Lemoine; Carl Schulz; Jascha Sani; Johannes Petersen; Hermann Reichenspurner; Paulus Kirchhof; Thomas Jespersen; Thomas Eschenhagen; Arne Hansen; Jussi T Koivumäki; Torsten Christ
Journal:  Cells       Date:  2022-08-05       Impact factor: 7.666

9.  Sensitivity analysis revealing the effect of modulating ionic mechanisms on calcium dynamics in simulated human heart failure.

Authors:  Maria T Mora; Jose M Ferrero; Lucia Romero; Beatriz Trenor
Journal:  PLoS One       Date:  2017-11-08       Impact factor: 3.240

10.  The Effects of SEA0400 on Ca2+ Transient Amplitude and Proarrhythmia Depend on the Na+/Ca2+ Exchanger Expression Level in Murine Models.

Authors:  Nils Bögeholz; Jan S Schulte; Sven Kaese; B Klemens Bauer; Paul Pauls; Dirk G Dechering; Gerrit Frommeyer; Joshua I Goldhaber; Uwe Kirchhefer; Lars Eckardt; Christian Pott; Frank U Müller
Journal:  Front Pharmacol       Date:  2017-09-21       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.